To include your compound in the COVID-19 Resource Center, submit it here.

Neotrofin leteprinim: Phase II data

In a 19-patient U.S. Phase II trial, 500 mg and 1000 mg doses of Neotrofin

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE